Publications by authors named "Richard Egleton"

Claim this Profile
M
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer.
Cora E Miracle, Chelsea L McCallister, Richard D Egleton, Travis B Salisbury

Biochem Biophys Res Commun· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intake assessments of salivary cortisol, survey responses, and adverse childhood experiences are associated with recovery success in an abstinence-based treatment program for substance use disorders.
Taylor R Maddox-Rooper, Kristiana Sklioutouskaya-Lopez, Trenton Sturgill, Caroline Fresch, Charles W Clements, Richard Egleton

Alcohol Clin Exp Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in Excitatory and Inhibitory Synaptic Development Within the Mesolimbic Dopamine Pathway in a Mouse Model of Prenatal Drug Exposure.
Taylor Boggess, James C Williamson, Ethan B Niebergall, Hannah Sexton, Anna Mazur, Richard D Egleton

Front Pediatr· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
History of postpartum depression as a contributor to the severity of NAS.
Emma M Nellhaus, Louis Nieuwenhuizen, Richard Egleton, Zachary Hansen, David Chaffin

Addict Behav· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptides at the blood brain barrier: Knowing me knowing you.
Thomas P Davis, Thomas J Abbruscato, Richard D Egleton

Peptides· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug abuse and the neurovascular unit.
Richard D Egleton, Thomas Abbruscato

Adv Pharmacol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A paradigm shift for evaluating pharmacotherapy for Alzheimer's disease: the 10-patient screening protocol.
James D Weinstein, Edgar R Gonzalez, Richard D Egleton, David A Hunt

Consult Pharm· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MG624, an α7-nAChR antagonist, inhibits angiogenesis via the Egr-1/FGF2 pathway.
Kathleen C Brown, Jamie K Lau, Aaron M Dom, Theodore R Witte, Haitao Luo, Richard D Egleton

Angiogenesis· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.
Aaron M Dom, Adam W Buckley, Kathleen C Brown, Richard D Egleton, Aileen J Marcelo

Invest Ophthalmol Vis Sci· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.
Richard D Egleton, Kathleen C Brown, Piyali Dasgupta

Pharmacol Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier.
Christopher R Campos, Scott M Ocheltree, Sharon Hom, Richard D Egleton, Thomas P Davis

Brain Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis.
Richard D Egleton, Kathleen C Brown, Piyali Dasgupta

Trends Pharmacol Sci· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tight junctions contain oligomeric protein assembly critical for maintaining blood-brain barrier integrity in vivo.
Gwen McCaffrey, William D Staatz, Carolyn A Quigley, Nicole Nametz, Melissa J Seelbach, Richard D Egleton

J Neurochem· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiology of the blood-brain barrier: animal models and methods.
Brian T Hawkins, Richard D Egleton

Curr Top Dev Biol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral inflammatory hyperalgesia modulates morphine delivery to the brain: a role for P-glycoprotein.
Melissa J Seelbach, Tracy A Brooks, Richard D Egleton, Thomas P Davis

J Neurochem· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats.
Sharon Hom, Melissa A Fleegal, Richard D Egleton, Christopher R Campos, Brian T Hawkins

Am J Physiol Regul Integr Comp Physiol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased blood-brain barrier permeability to fluorescein in streptozotocin-treated rats.
Brian T Hawkins, Scott M Ocheltree, Kristi M Norwood, Richard D Egleton

Neurosci Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biphasic cytoarchitecture and functional changes in the BBB induced by chronic inflammatory pain.
Tracy A Brooks, Scott M Ocheltree, Melissa J Seelbach, Rachael A Charles, Nicole Nametz, Richard D Egleton

Brain Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorescence imaging of blood-brain barrier disruption.
Brian T Hawkins, Richard D Egleton

J Neurosci Methods· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic inflammatory pain leads to increased blood-brain barrier permeability and tight junction protein alterations.
Tracy A Brooks, Brian T Hawkins, Jason D Huber, Richard D Egleton, Thomas P Davis

Am J Physiol Heart Circ Physiol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of cerebral microvascular permeability by endothelial nicotinic acetylcholine receptors.
Brian T Hawkins, Richard D Egleton, Thomas P Davis

Am J Physiol Heart Circ Physiol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycopeptides related to beta-endorphin adopt helical amphipathic conformations in the presence of lipid bilayers.
Muthu Dhanasekaran, Michael M Palian, Isabel Alves, Larisa Yeomans, Charles M Keyari, Richard D Egleton

J Am Chem Soc· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of neuropeptide drugs that cross the blood-brain barrier.
Richard D Egleton, Thomas P Davis

NeuroRx· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotine increases in vivo blood-brain barrier permeability and alters cerebral microvascular tight junction protein distribution.
Brian T Hawkins, Thomas J Abbruscato, Richard D Egleton, Rachel C Brown, Jason D Huber

Brain Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
Rachel C Brown, Richard D Egleton, Thomas P Davis

Brain Res· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis